Published Paper Indicates Leronlimab Shows Activity Against 4-Class Drug Resistant HIV-1
Should we, as investors and the medical community, be excited about LL showing "activity"?
The market seems excited - up .08 cents and 8%.
(2)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-
